X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4119) 4119
Book Review (1854) 1854
Publication (516) 516
Book Chapter (104) 104
Conference Proceeding (31) 31
Book / eBook (19) 19
Dissertation (3) 3
Newspaper Article (3) 3
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3105) 3105
humans (2583) 2583
oncology (1453) 1453
molecular targeted therapy (1298) 1298
mutation (1178) 1178
cancer (1158) 1158
targeted therapy (1068) 1068
animals (759) 759
female (741) 741
genetic aspects (670) 670
genomics (661) 661
male (573) 573
research (565) 565
antineoplastic agents - therapeutic use (554) 554
care and treatment (529) 529
chemotherapy (507) 507
analysis (506) 506
genes (489) 489
tumors (483) 483
health aspects (452) 452
article (433) 433
mutations (421) 421
genomes (418) 418
genetics & heredity (395) 395
review (391) 391
precision medicine (377) 377
next-generation sequencing (372) 372
molecular targeted therapy - methods (369) 369
middle aged (356) 356
prognosis (349) 349
gene expression (339) 339
biochemistry & molecular biology (336) 336
high-throughput nucleotide sequencing (328) 328
cell biology (326) 326
adult (322) 322
immunotherapy (317) 317
metastasis (312) 312
deoxyribonucleic acid--dna (308) 308
neoplasms - genetics (308) 308
open-label (308) 308
pharmacology & pharmacy (298) 298
biomarkers, tumor - genetics (288) 288
aged (287) 287
biomarkers (286) 286
genetics (285) 285
antineoplastic agents - pharmacology (280) 280
lung cancer (274) 274
neoplasms - drug therapy (273) 273
genetic research (269) 269
medicine & public health (269) 269
pathology (269) 269
diagnosis (268) 268
proteins (260) 260
cancer therapies (259) 259
patients (254) 254
cell lung-cancer (251) 251
expression (250) 250
gene mutations (249) 249
breast cancer (237) 237
targeted therapies (237) 237
hematology (230) 230
clinical trials (229) 229
gene (228) 228
hematology, oncology and palliative medicine (227) 227
kinases (227) 227
lung neoplasms - genetics (226) 226
biotechnology & applied microbiology (223) 223
development and progression (221) 221
dna sequencing (219) 219
therapy (214) 214
treatment outcome (214) 214
medicine (210) 210
phenotype (210) 210
signal transduction (210) 210
dna (208) 208
drug therapy (207) 207
medical research (204) 204
usage (204) 204
medicine, research & experimental (199) 199
protein kinase inhibitors - therapeutic use (199) 199
acquired-resistance (194) 194
breast-cancer (194) 194
next generation sequencing (194) 194
targeted mutagenesis (192) 192
high-throughput nucleotide sequencing - methods (187) 187
methods (187) 187
personalized medicine (186) 186
lung neoplasms - drug therapy (185) 185
identification (184) 184
resistance (183) 183
signal transduction - drug effects (181) 181
gene expression regulation, neoplastic (180) 180
genetic predisposition to disease (176) 176
nucleotide sequencing (175) 175
melanoma (172) 172
precision medicine - methods (171) 171
clinical trials as topic (167) 167
multidisciplinary sciences (163) 163
phase-ii trial (163) 163
mice (160) 160
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Missing (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
St. Michael's Hospital - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4151) 4151
German (35) 35
French (11) 11
Japanese (9) 9
Chinese (3) 3
Korean (3) 3
Russian (2) 2
Hungarian (1) 1
Polish (1) 1
Portuguese (1) 1
Spanish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Cancer Research, ISSN 1078-0432, 05/2014, Volume 20, Issue 9, pp. 2476 - 2484
Journal Article
The Oncologist, ISSN 1083-7159, 03/2014, Volume 19, Issue 3, pp. 235 - 242
Journal Article
BMC Cancer, ISSN 1471-2407, 01/2014, Volume 14, Issue 1, pp. 13 - 13
Journal Article
European Urology, ISSN 0302-2838, 2017, Volume 72, Issue 6, pp. 952 - 959
Abstract Background Molecular characterization of nonmuscle invasive bladder cancer (NMIBC) may provide a biologic rationale for treatment response and novel... 
Urology | Bacillus Calmette-Guérin | DNA damage repair | Nonmuscle invasive bladder cancer | Targeted therapy | Genomics | Immunotherapy | AT-Rich interaction domain 1A | SURVIVAL | UROTHELIAL CARCINOMA | INACTIVATION | Bacillus Calmette-Guerin | ANEUPLOIDY | STAG2 | HIGH-RISK | URINE | UROLOGY & NEPHROLOGY | GRADE | MUTATIONS | PROMOTER | Class I Phosphatidylinositol 3-Kinases - genetics | Receptor, ErbB-2 - genetics | Exons | Humans | Middle Aged | Male | DNA Repair - genetics | Molecular Targeted Therapy | Histone Demethylases - genetics | Tumor Suppressor Protein p53 - genetics | DNA Copy Number Variations | Neoplasm Grading | Telomerase - genetics | Urinary Bladder Neoplasms - genetics | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | DNA Damage - genetics | Adult | Female | Nuclear Proteins - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Neoplasm Invasiveness | Kaplan-Meier Estimate | Proportional Hazards Models | Gene Fusion | Transcription Factors - genetics | Cystectomy | Antigens, Nuclear - genetics | Antineoplastic Agents, Immunological - therapeutic use | Urinary Bladder Neoplasms - therapy | Biomarkers | Neoplasm Recurrence, Local - genetics | Aged | High-Throughput Nucleotide Sequencing | BCG Vaccine - therapeutic use | Mutation | Neoplasm Staging | Bladder cancer | Health aspects | Analysis | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2919 - 2928
Journal Article
Cancer, ISSN 0008-543X, 02/2015, Volume 121, Issue 4, pp. 631 - 639
Journal Article
Cancer, ISSN 0008-543X, 12/2016, Volume 122, Issue 24, pp. 3838 - 3847
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 6, pp. 1780 - 1787
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2013, Volume 8, Issue 11, pp. e80478 - e80478
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 07/2018, Volume 17, Issue 7, pp. 1595 - 1601
The European Society for Medical Oncology defines rare cancers as 5 or fewer cases per 100,000 persons per year. For many rare cancers, no standard of care... 
CELL LUNG-CANCER | TARGETED THERAPY | DABRAFENIB | MULTICENTER | GENOMICS | ONCOLOGY | LANDSCAPE | TRAMETINIB | OPEN-LABEL | Medical research | Therapy | Adenoid | Profiling | p53 Protein | Medical services | Clinical trials | Disease control | Patients | AACR | Alterations | Mutation | Cholangiocarcinoma | Tumors | Cancer | Rare cancers | Precision Oncology | Targeted therapy | Phase I trials
Journal Article
Journal Article